JACC: CardioOncology

Scope & Guideline

Advancing the Frontiers of Cardiac and Cancer Care

Introduction

Explore the comprehensive scope of JACC: CardioOncology through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore JACC: CardioOncology in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2666-0873
PublisherELSEVIER
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2019 to 2024
AbbreviationJACC-CARDIOONCOL / JACC-Cardiooncol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

JACC: CardioOncology is dedicated to advancing the understanding and management of cardiovascular complications in cancer patients. It focuses on the intersection of cardiology and oncology, emphasizing the need for integrated care strategies that address both cancer treatment and cardiovascular health.
  1. Cardiovascular Risk Assessment in Cancer Patients:
    The journal emphasizes the importance of accurately assessing cardiovascular risks in cancer patients, particularly those undergoing chemotherapy and radiotherapy, to mitigate potential cardiovascular complications.
  2. Management of Cardiotoxicity:
    Research published in the journal frequently addresses the mechanisms of cardiotoxicity from various cancer treatments, including chemotherapy and immunotherapy, and explores strategies for prevention and management.
  3. Impact of Cancer Treatments on Cardiac Health:
    The journal focuses on how different cancer therapies, such as anthracyclines and immune checkpoint inhibitors, affect cardiac function, leading to conditions like heart failure or arrhythmias.
  4. Social Determinants and Health Disparities:
    There is a growing emphasis on understanding how social determinants of health influence cardiovascular outcomes in cancer patients, addressing disparities in care and outcomes.
  5. Innovative Therapeutic Approaches:
    The journal highlights novel therapeutic strategies, including the use of biomarkers, genetic screening, and new pharmacological agents aimed at protecting cardiac health in cancer patients.
Recent publications in JACC: CardioOncology indicate a dynamic evolution in research themes, with several areas gaining increased attention. These emerging scopes reflect the journal's commitment to addressing contemporary challenges in cardio-oncology.
  1. Integration of Artificial Intelligence and Technology:
    There is a notable trend towards utilizing artificial intelligence and advanced imaging technologies to enhance cardiovascular risk prediction and management in cancer patients.
  2. Personalized Medicine and Genomic Approaches:
    The journal is increasingly focusing on personalized medicine, exploring genetic predispositions to cardiotoxicity and tailoring treatment plans based on individual patient profiles.
  3. Health Equity and Disparities in Care:
    Emerging themes highlight the importance of addressing health equity, focusing on disparities in cardiovascular care among diverse populations affected by cancer.
  4. Exercise and Rehabilitation in Cancer Survivors:
    There is a growing emphasis on the role of physical activity and rehabilitation programs in improving cardiovascular health and overall quality of life for cancer survivors.
  5. Long-Term Cardiovascular Monitoring and Follow-Up:
    The trend is moving towards establishing protocols for long-term cardiovascular monitoring of cancer survivors to detect and manage late-onset cardiovascular complications.

Declining or Waning

While JACC: CardioOncology continues to grow in various areas, some themes appear to be declining in prominence. These waning themes reflect shifting priorities and advancements in research focus within the field.
  1. Traditional Cardiovascular Risk Factors:
    There seems to be a decreasing emphasis on traditional cardiovascular risk factors in isolation, as the focus shifts towards integrated approaches that consider the unique cardiovascular challenges posed by cancer therapies.
  2. General Cardiovascular Guidelines:
    General cardiovascular guidelines without specific adaptations for cancer patients are becoming less relevant, as the journal increasingly prioritizes tailored guidelines that address the complexities of treating patients with coexisting cancer and cardiovascular disease.
  3. Single-Disease Focus:
    Research that solely examines cardiovascular issues without considering the cancer context is declining, as the journal emphasizes the importance of understanding the interplay between cancer treatment and cardiovascular health.

Similar Journals

International Heart Journal

Elevating Understanding of Heart Disease Worldwide
Publisher: INT HEART JOURNAL ASSOCISSN: 1349-2365Frequency: 6 issues/year

International Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.

Indian Heart Journal

Exploring Heart Health Innovations Across Borders
Publisher: ELSEVIERISSN: 0019-4832Frequency: 6 issues/year

Indian Heart Journal, published by Elsevier, is a distinguished peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. Founded in 1961, this journal has been a pivotal resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and insights into heart health. The journal transitioned to an Open Access model in 2013, ensuring widespread dissemination of vital research findings to enhance global understanding of cardiovascular diseases. Ranked in the Q3 category for Cardiology and Cardiovascular Medicine in 2023, it holds a reputable position in the medical community, with a Scopus rank of #222 out of 387 journals in the same field, placing it in the 42nd percentile. The Indian Heart Journal strives to foster advances in clinical practice and research while addressing the unique cardiac health challenges faced in India and beyond.

Current Cardiology Reports

Innovative insights driving the future of cardiology.
Publisher: SPRINGERISSN: 1523-3782Frequency: 12 issues/year

Current Cardiology Reports, published by Springer, is a leading peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine. With its ISSN 1523-3782 and E-ISSN 1534-3170, the journal offers a platform for researchers and practitioners to share innovative research findings, clinical insights, and comprehensive reviews, contributing to the ongoing dialogue in cardiovascular health. Recognized for its high impact, Current Cardiology Reports holds a prestigious Q1 ranking in the Cardiology category for 2023 and ranks #83 out of 387 in Scopus, placing it in the 78th percentile among journals in its field. The journal, converging its insights from 1999 to 2024, aims to disseminate valuable knowledge that can inform clinical practice and influence future research directions. Although not an Open Access journal, the rich content and timely articles published within its pages are invaluable to both seasoned professionals and emerging scholars in cardiology. Based in New York, United States, the journal continues to play a critical role in shaping cardiovascular medicine through rigorous scientific inquiry and education.

THORACIC AND CARDIOVASCULAR SURGEON

Transforming patient care through cutting-edge research.
Publisher: GEORG THIEME VERLAG KGISSN: 0171-6425Frequency: 8 issues/year

THORACIC AND CARDIOVASCULAR SURGEON, published by GEORG THIEME VERLAG KG, is a prestigious journal dedicated to the fields of cardiology, cardiovascular surgery, and pulmonary medicine. Since its inception in 1973, the journal has served as a vital platform for disseminating cutting-edge research and innovative techniques, contributing significantly to advancements in patient care and surgical practices. With an emerging recognition evidenced by its category quartiles, ranking Q3 in Cardiology and Cardiovascular Medicine and Q2 in Surgery as of 2023, it positions itself as an essential resource for both clinicians and researchers alike. Although this journal does not currently offer Open Access options, it maintains a strong impact with Scopus rankings that highlight its relevance within the medicine and surgery disciplines. The journal is particularly committed to bridging the gap between theoretical research and practical application, making it crucial for professionals aiming to stay informed on the latest developments in thoracic and cardiovascular health. Join a community of scholars dedicated to excellence in these critical areas of medicine.

Cardiovascular Toxicology

Exploring the critical intersection of toxicology and cardiology.
Publisher: HUMANA PRESS INCISSN: 1530-7905Frequency: 6 issues/year

Cardiovascular Toxicology is a pivotal journal dedicated to advancing the understanding of the interplay between toxic substances and cardiovascular health. Published by HUMANA PRESS INC, this journal serves as a critical resource for researchers and professionals in the fields of cardiology, toxicology, and molecular biology. With an ISSN of 1530-7905 and an E-ISSN of 1559-0259, it has established itself as a key source of high-quality research since its inception in 2001, continuing to contribute valuable insights through 2024. The journal enjoys a robust reputation, evidenced by its Q2 ranking in both Cardiology and Cardiovascular Medicine and Toxicology, along with a Q3 ranking in Molecular Biology for 2023. With Scopus rankings placing it in the 80th percentile for Cardiology and 71st for Toxicology, Cardiovascular Toxicology attracts submissions that reflect cutting-edge research and innovative methodologies. Notably, the journal prioritizes stringent peer review and scholarly rigor, ensuring that published works significantly impact the understanding of cardiovascular responses to various toxic agents. Though not an open-access journal, its content remains highly sought after in a diverse scholarly community, making it indispensable for those dedicated to enhancing cardiovascular disease prevention, diagnosis, and treatment through toxicological insights.

AMERICAN JOURNAL OF CARDIOLOGY

Advancing Cardiovascular Knowledge for a Healthier Tomorrow
Publisher: EXCERPTA MEDICA INC-ELSEVIER SCIENCE INCISSN: 0002-9149Frequency: 24 issues/year

The American Journal of Cardiology is a leading peer-reviewed journal in the field of Cardiology and Cardiovascular Medicine, published by Excerpta Medica Inc-Elsevier Science Inc. Since its inception in 1958, the journal has consistently contributed to the advancement of cardiovascular research, providing a platform for groundbreaking studies and clinical findings that shape modern medical practices. With an impressive impact factor placing it in the Q1 category in its field for 2023, it ranks among the top journals in medicine, with a rank of #155 out of 387 in the Scopus database, reflecting its significance and rigorous editorial standards. The journal is committed to disseminating high-quality research that fosters innovation and enhances clinical outcomes in cardiology. Although it does not provide Open Access options, the American Journal of Cardiology remains an essential resource for researchers, healthcare professionals, and students looking to deepen their understanding of cardiovascular health.

Revista Portuguesa de Cardiologia

Transforming cardiovascular medicine with cutting-edge research.
Publisher: ELSEVIER ESPANA SLUISSN: 0870-2551Frequency: 12 issues/year

Revista Portuguesa de Cardiologia, published by Elsevier España SLU, stands as a pivotal resource in the realm of Cardiology and Cardiovascular Medicine. With its origins tracing back to 1970, this journal has cultivated a robust academic presence, achieving a 2023 Q3 ranking in its category, and currently holding a position of #220 out of 387 on the Scopus rankings, placing it within the 43rd percentile of its field. This open access journal, available since 2011, aims to disseminate high-quality research and insights relevant to contemporary cardiovascular issues. Its commitment to accessibility and knowledge exchange enhances its importance for clinicians, researchers, and students alike, fostering a more informed community in the fight against cardiovascular diseases. Operating from its base in Barcelona, Spain, the journal welcomes contributions that further the understanding and treatment of heart conditions, contributing significantly to the advancement of cardiovascular health.

Arquivos Brasileiros de Cardiologia

Exploring the frontiers of cardiovascular science since 1950.
Publisher: ARQUIVOS BRASILEIROS CARDIOLOGIAISSN: 0066-782XFrequency: 12 issues/year

Arquivos Brasileiros de Cardiologia is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. Established in 1950 and published by the ARQUIVOS BRASILEIROS CARDIOLOGIA, this Brazilian journal plays a crucial role in disseminating high-quality research that addresses both emerging and established topics in cardiovascular science. With an impressive history and a commitment to open access since 1997, it provides researchers, healthcare professionals, and students with free and readily available content that significantly contributes to the understanding and management of cardiovascular diseases. The journal is indexed in Scopus and holds a Q3 ranking in the category of Cardiology and Cardiovascular Medicine, demonstrating its relevance and participation within the global research community. Researchers can submit their work and access a wealth of information that spans a variety of subfields, reflecting the journal’s dedication to fostering innovation and collaboration within cardiology. With a mailing address at Avenida Marechal Câmara, 160-330 Centro, Rio de Janeiro, RJ 20,020-907, Brazil, the journal continues to serve as a vital platform for scholarly communication and knowledge exchange in the cardiovascular realm.

Cardio-Oncology

Transforming Patient Care: Exploring the Intersection of Heart and Cancer
Publisher: BMCISSN: Frequency: 1 issue/year

Cardio-Oncology, published by BMC since 2015, serves as a premier open-access journal dedicated to the intersection of cardiology and oncology, ensuring that vital research reaches a global audience without barriers. With an impactful presence in the United Kingdom and an impressive Q1 ranking in Cardiology and Cardiovascular Medicine, alongside a Q2 ranking in Oncology as of 2023, the journal captures the growing importance of managing cardiovascular health in cancer patients. Aimed at researchers, healthcare professionals, and students, Cardio-Oncology publishes high-quality research, reviews, and clinical studies that advance understanding in this critical field, fostering an interdisciplinary dialogue essential for improving patient outcomes. Accessible and relevant, the journal reflects the concerted effort to bridge gaps in knowledge and address the complexities faced by healthcare providers managing the dual challenges of cancer and cardiovascular disease.

Kardiologia Polska

Innovative Research for a Healthier Tomorrow
Publisher: POLISH CARDIAC SOCISSN: 0022-9032Frequency: 12 issues/year

Kardiologia Polska, the esteemed journal of the Polish Cardiac Society, has established itself as a vital resource in the field of cardiology and cardiovascular medicine since its inception in 1954. With an ISSN of 0022-9032 and an E-ISSN of 1897-4279, this journal serves as a platform for groundbreaking research and scholarly articles that contribute to the advancement of heart health. Although currently not an open access journal, it remains an essential reference for practitioners and researchers seeking to stay abreast of the latest developments in cardiovascular science. The journal reflects its scholarly depth through a Category Quartile of Q3 and a commendable Scopus ranking at the 48th percentile in its field. Published primarily in Poland, it caters to a global audience eager to explore comprehensive studies spanning clinical cardiology, innovative therapeutic approaches, and emerging cardiovascular trends. Join a thriving academic community by engaging with the invaluable insights and research contributions found within the pages of Kardiologia Polska.